Latest arrival: Over 1.2 million Sinovac, Sinopharm COVID-19 vaccine doses | Inquirer News
Close  

Latest arrival: Over 1.2 million Sinovac, Sinopharm COVID-19 vaccine doses

/ 08:26 AM August 21, 2021

PHOTO COURTESY OF NTF AGAINST COVID-19

MANILA, Philippines — Over 1.2 million doses of Sinopharm and Sinovac’s COVID-19 vaccine arrived in the country on Saturday.

The National Taskforce Against COVID-19 said a total of one million procured doses of Sinovac and 260,800 donated Sinopharm doses arrived at the Ninoy Aquino International Airport.

ADVERTISEMENT

 The Sinopharm shipment ispart of the 1 million doses donated by the Chinese government.

An initial 739,200  Sinopharm vaccine doses arrived in the country on Friday.

FEATURED STORIES

As of Wednesday, over 12.8 million individuals in the country have been fully vaccinated against COVID-19.

 gsg

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: COVID-19, NTF, Sinopharm, Sinovac, vaccine arrival
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.